| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800028 | 重组抗PD-L1全人源单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-03-26 | 海正药业（杭州）有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2018-08-07 | view |